A detailed history of Gabelli Funds LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 40,300 shares of BIO stock, worth $13.3 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
40,300
Previous 41,800 3.59%
Holding current value
$13.3 Million
Previous $11.4 Million 18.12%
% of portfolio
0.11%
Previous 0.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$263.97 - $344.64 $395,955 - $516,960
-1,500 Reduced 3.59%
40,300 $13.5 Million
Q1 2024

May 14, 2024

BUY
$304.11 - $351.99 $1.82 Million - $2.11 Million
6,000 Added 16.76%
41,800 $14.5 Million
Q3 2023

Nov 08, 2023

SELL
$350.25 - $422.63 $490,350 - $591,682
-1,400 Reduced 3.76%
35,800 $12.8 Million
Q2 2023

Aug 10, 2023

BUY
$359.49 - $486.4 $179,745 - $243,200
500 Added 1.36%
37,200 $14.1 Million
Q4 2022

Feb 13, 2023

SELL
$351.71 - $456.01 $35,171 - $45,601
-100 Reduced 0.27%
36,700 $15.4 Million
Q3 2022

Nov 10, 2022

BUY
$412.59 - $563.26 $412,590 - $563,260
1,000 Added 2.79%
36,800 $15.4 Million
Q2 2022

Aug 12, 2022

BUY
$463.67 - $597.16 $3.25 Million - $4.18 Million
7,000 Added 24.31%
35,800 $17.7 Million
Q1 2022

May 13, 2022

BUY
$524.57 - $735.42 $154,748 - $216,948
295 Added 1.03%
28,800 $16.2 Million
Q3 2021

Nov 12, 2021

SELL
$657.71 - $825.77 $6.28 Million - $7.89 Million
-9,550 Reduced 25.1%
28,505 $21.3 Million
Q2 2021

Aug 13, 2021

BUY
$576.64 - $649.04 $720,800 - $811,300
1,250 Added 3.4%
38,055 $24.5 Million
Q1 2021

May 14, 2021

SELL
$547.01 - $662.35 $547,010 - $662,350
-1,000 Reduced 2.65%
36,805 $21 Million
Q4 2020

Feb 05, 2021

SELL
$510.68 - $643.45 $727,719 - $916,916
-1,425 Reduced 3.63%
37,805 $22 Million
Q3 2020

Nov 06, 2020

SELL
$454.43 - $535.6 $1.15 Million - $1.35 Million
-2,520 Reduced 6.04%
39,230 $20.2 Million
Q2 2020

Aug 13, 2020

SELL
$334.87 - $493.06 $937,636 - $1.38 Million
-2,800 Reduced 6.29%
41,750 $18.9 Million
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $48,001 - $61,360
150 Added 0.34%
44,550 $15.6 Million
Q4 2019

Feb 14, 2020

BUY
$319.73 - $374.2 $735,379 - $860,660
2,300 Added 5.46%
44,400 $16.4 Million
Q3 2019

Nov 01, 2019

SELL
$304.55 - $345.24 $243,640 - $276,192
-800 Reduced 1.86%
42,100 $14 Million
Q2 2019

Aug 02, 2019

BUY
$286.93 - $312.59 $1.23 Million - $1.34 Million
4,300 Added 11.14%
42,900 $13.4 Million
Q1 2019

May 02, 2019

BUY
$224.3 - $317.41 $3.45 Million - $4.89 Million
15,400 Added 66.38%
38,600 $11.8 Million
Q4 2018

Jan 30, 2019

SELL
$220.1 - $309.0 $396,180 - $556,200
-1,800 Reduced 7.2%
23,200 $5.39 Million
Q3 2018

Nov 02, 2018

SELL
$289.28 - $326.15 $86,783 - $97,845
-300 Reduced 1.19%
25,000 $7.83 Million
Q2 2018

Aug 10, 2018

SELL
$244.1 - $303.88 $903,170 - $1.12 Million
-3,700 Reduced 12.76%
25,300 $7.3 Million
Q1 2018

May 09, 2018

SELL
$233.97 - $274.11 $584,925 - $685,275
-2,500 Reduced 7.94%
29,000 $7.25 Million
Q4 2017

Feb 02, 2018

SELL
$216.94 - $271.3 $1.63 Million - $2.03 Million
-7,500 Reduced 19.23%
31,500 $7.52 Million
Q3 2017

Nov 01, 2017

BUY
$212.27 - $242.28 $8.28 Million - $9.45 Million
39,000
39,000 $8.67 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.14B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.